Recent advances in the diagnosis and management of carcinoid syndrome
N Subash, MM Papali, KP Bahadur, C Avanthika… - Disease-a-Month, 2022 - Elsevier
Carcinoid syndrome, a paraneoplastic condition linked with the release of multiple humoral
factors, affects around 30-40% of patients with well-differentiated neuroendocrine tumours …
factors, affects around 30-40% of patients with well-differentiated neuroendocrine tumours …
[引用][C] Recent Advances in the Diagnosis and Management of Carcinoid Syndrome
N Subash, MM Papali, KP Bahadur, C Avanthika… - Disease-a-Month, 2021 - elibrary.ru
Recent Advances in the Diagnosis and Management of Carcinoid Syndrome
N Subash, MM Papali, KP Bahadur… - … -a-month: DM, 2022 - pubmed.ncbi.nlm.nih.gov
Carcinoid syndrome, a paraneoplastic condition linked with the release of multiple humoral
factors, affects around 30-40% of patients with well-differentiated neuroendocrine tumours …
factors, affects around 30-40% of patients with well-differentiated neuroendocrine tumours …
Recent Advances in the Diagnosis and Management of Carcinoid Syndrome.
N Subash, MM Papali, KP Bahadur… - Disease-a-month …, 2021 - europepmc.org
Carcinoid syndrome, a paraneoplastic condition linked with the release of multiple humoral
factors, affects around 30-40% of patients with well-differentiated neuroendocrine tumours …
factors, affects around 30-40% of patients with well-differentiated neuroendocrine tumours …